All Movers & Shakers

Monika Neuman Joins Gentian Diagnostics's Board Members

2022 27 Jun

Monika Neuman has 20 years of experience from the diagnostics industry, currently holding a position as Managing Director for Sarstedt Group in the Nordics. She has previously had several international and commercial leadership roles like Head of Sales, EMEA , and VP Global Business Management. During the past 4 years, Ms. Neuman has been working at... Read more

Elena Bonfiglioli Starts a New Position at Microsoft Healthcare

2022 27 Jun

Elena Bonfiglioli is the new General Manager Healthcare, Pharma Life Sciences at Microsoft Healthcare. As lead for Health and Life Sciences, Elena is responsible to drive strategy, advance the digital transformation agenda with health and pharma customers, and represent Microsoft’s industry position, working together with a community of over 250+ professionals... Read more

Appointment of Vice President of Investor Relations

2022 27 Jun

Abcam  plc, a global leader in the supply of life science research tools, today announces the appointment of  Tommy Thomas  as Vice President of Investor Relations. Tommy, who will be based in our  Waltham, MA  office, has over 20 years' experience in the life sciences sector, largely focused in the area of research tools. He joins Abcam from... Read more

Valo Therapeutics Appoints Experienced Life Sciences Executive Anthony Giovinazzo to Board

2022 27 Jun

Valo Therapeutics Oy, the developer of novel, adaptable immunotherapy platforms for cancer and infectious diseases announced the appointment of an accomplished life sciences executive. Anthony Giovinazzo will bring his considerable track record of capital raising, drug development, and company leadership in North America to the company’s Board of Directors.... Read more

Blueprint Medicines Appoints Habib Dable to its Board of Directors

2022 23 Jun

Blueprint Medicines Corporation announced the appointment of  Habib Dable  to its board of directors. Mr. Dable, who was Chief Executive Officer of Acceleron Pharma from 2016 to 2021, brings nearly 30 years of experience in strategic leadership, commercial growth and organizational scale across global pharmaceutical and emerging biotechnology companies.... Read more

Tevogen Bio Appoints Dr. Kendell R. Sprot to Corporate Advisory Board

2022 23 Jun

Tevogen Bio, a late-stage biotechnology company specializing in developing cell and gene therapies in oncology, neurology, and virology announced that its Board of Directors has appointed Kendell R. Sprott, M.D., J.D., to its Corporate Advisory Board. Most recently, Dr. Sprott served six years as President and CEO at  Matheny  Medical and Educational... Read more

Stella Appoints Dr. Pat Basu as Chairman

2022 22 Jun

Dr. Basu, a veteran healthcare CEO, entrepreneur and former White House Fellow, will broaden Stella's reach to millions who suffer daily from emotional trauma symptoms. Stella , the leader in the delivery of high outcome treatments for emotional trauma and mental health management announced the appointment of Dr. Pat Basu as Chairman of its... Read more

Radiology Partners Names Dr. Krishna Nallamshetty Chief Medical Officer

2022 22 Jun

Continued emphasis on elevating radiologists to senior executive leadership roles Radiology Partners  (RP), the leading radiology practice in the U.S., announced today that Dr. Krishna Nallamshetty ( @knallamMD ) has been appointed to serve as the practice’s next Chief Medical Officer (CMO) effective immediately. As a member of RP’s  senior leadership... Read more

Prolucent Health Appoints Joseph Cabral As Chief Growth Officer

2022 21 Jun

Prolucent Health ®, a leading provider of enterprise-wide healthcare workforce optimization software and services announced the appointment of  Joseph Cabral  as Chief Growth Officer to drive new client relationships, develop go-to-market strategies, support sales initiatives, and further position Prolucent as a market leader in workforce optimization... Read more

LifePoint Health Appoints Two Leaders to Top Executive Positions

2022 21 Jun

Jason Zachariah named EVP, Chief Operating Officer  and Aaron Lewis named EVP, Growth and Integrated Solutions LifePoint Health®, a diversified healthcare delivery network dedicated to its mission of Making Communities Healthier® announced that two of the organization’s current leaders have been promoted to new executive leadership roles within... Read more

Dr. Andrew Kolodny Appointed President of Physicians for Responsible Opioid Prescribing

2022 21 Jun

Physicians for Responsible Opioid Prescribing (PROP)  has appointed Dr. Andrew Kolodny to succeed Dr. Jane Ballantyne as the organization’s next president. The appointment will become effective June 21, 2022. “I am delighted to serve in this role again, especially at a time when the need for more cautious opioid prescribing in the United States... Read more

Arcellx Announces Appointment Of Maryam Abdul-Kareem As General Counsel

2022 21 Jun

Arcellx, Inc.a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases announced the appointment of Maryam Abdul-Kareem, J.D., as General Counsel. Ms. Abdul-Kareem brings extensive legal and business expertise in the biopharmaceutical industry, including... Read more

Bryant Wong Named Sciton Inc. Chief Financial Officer

2022 21 Jun

Amidst A Year of Innovation & Growth Company Adds CFO To Leadership Team Sciton Inc., a leading manufacturer of medical and aesthetic lasers and light source technologies, proudly announces the promotion of Sciton employee,  Bryant Wong , who will serve as the company's first Chief Financial Officer at Sciton, effective immediately. The... Read more

QurAlis Announces the Appointment of Anne C. Whitaker as Chair of the Board

2022 21 Jun

Industry veteran brings proven track record in building successful businesses and leading high-performance teams across large pharmaceutical, biotech, and specialty pharma companies QurAlis Corporation , a biotech company developing breakthrough precision medicines for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases... Read more

North Star Announces Promotion of Frank Scholz, Ph.D., to President and Chief Operating Officer

2022 20 Jun

NorthStar Medical Technologies, LLC, a global innovator in the development, production and commercialization of diagnostic and therapeutic radiopharmaceuticals, today announced the promotion of one of its key executives.  The announcement comes as NorthStar reaches a pivotal stage in its growth and industry influence.  Dr. Frank Scholz has been named... Read more

Valo Therapeutics Appoints Hemanshu Shah as Chief Business Officer

2022 16 Jun

Valo Therapeutics Oy, the developer of novel, adaptable immunotherapy platforms for cancer and infectious diseases announced the appointment of Dr Hemanshu Shah as Chief Business Officer (CBO), based in the US. ValoTx’s CEO, Paul Higham, said, “I am delighted to welcome Dr Hemanshu Shah as our CBO. Hemanshu brings a wealth of business development... Read more

BioAgilytix Appoints Euan Menzies as Chairman and Chief Executive Officer

2022 16 Jun

BioAgilytix Labs, LLC a leading global contract research organization focused on supporting pharmaceutical and biotech partners in all phases of drug development, announces the appointment, effective immediately, of Euan Menzies as Chairman and CEO. Jim Datin is retiring from his executive management role but will continue to serve as a non-executive... Read more

David Webster Appointed New CEO of Body Vision Medical

2022 16 Jun

David Webster  has been appointed the new Chief Executive Officer (CEO) of Body Vision Medical, a medical device company whose mission is to make artificial intelligence (AI)-driven imaging the standard of care for diagnosis and treatment of endoluminal cancer. The company's first offering is an advanced imaging system that maximizes diagnosis of... Read more

Panorama Medicine Appoints Dr. Haishan Xiong as Chief Executive Officer

2022 16 Jun

Panorama Medicine,  a genomics and AI powered drug discovery company focusing on therapeutics for RNA splicing defects, appoints Dr. Haishan Xiong as Chief Executive Officer to lead the company in its quest to bring revolutionary drugs to patients. “We are thrilled to have Dr. Xiong join Panorama,” said Dr. Yi Xing, co-founder of Panorama.... Read more

Matthew Collingridge Starts a New Position at Beckman Coulter Diagnostics

2022 16 Jun

Matthew Collingridge is starting a new position as GM Performance Partnerships Europe at Beckman Coulter Diagnostics.  He will be responsible for the commercial leadership of Beckman Coulter Performance Partnership across Europe. Performance Partnerships catalyse the transformation of clinical laboratories into high-performing organisations through... Read more